CIMYM BioSciences (Nimotuzumab Assets) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

CIMYM BioSciences (Nimotuzumab Assets) General Information

Description

A drug asset.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • London
  • England, United Kingdom
Primary Industry
Buildings and Property
Acquirer
Corporate Office
  • London
  • England, United Kingdom

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

CIMYM BioSciences (Nimotuzumab Assets) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore CIMYM BioSciences (Nimotuzumab Assets)‘s full profile, request access.

Request a free trial

CIMYM BioSciences (Nimotuzumab Assets) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore CIMYM BioSciences (Nimotuzumab Assets)‘s full profile, request access.

Request a free trial

CIMYM BioSciences (Nimotuzumab Assets) FAQs

  • Where is CIMYM BioSciences (Nimotuzumab Assets) headquartered?

    CIMYM BioSciences (Nimotuzumab Assets) is headquartered in London, United Kingdom.

  • What industry is CIMYM BioSciences (Nimotuzumab Assets) in?

    CIMYM BioSciences (Nimotuzumab Assets)’s primary industry is Buildings and Property.

  • Is CIMYM BioSciences (Nimotuzumab Assets) a private or public company?

    CIMYM BioSciences (Nimotuzumab Assets) is a Private company.

  • What is CIMYM BioSciences (Nimotuzumab Assets)’s current revenue?

    The current revenue for CIMYM BioSciences (Nimotuzumab Assets) is .

  • Who are CIMYM BioSciences (Nimotuzumab Assets)’s investors?

    CIMYM BioSciences has invested in CIMYM BioSciences (Nimotuzumab Assets).

  • When was CIMYM BioSciences (Nimotuzumab Assets) acquired?

    CIMYM BioSciences (Nimotuzumab Assets) was acquired on 03-Dec-2012.

  • Who acquired CIMYM BioSciences (Nimotuzumab Assets)?

    CIMYM BioSciences (Nimotuzumab Assets) was acquired by Innokeys.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process